The Economic Burden of Chronic Kidney Disease in Vietnam.

Autor:	Nguyen-Thi HY; Department of Pharmaceutical Administratrion, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Le-Phuoc TN; Department of Pharmacy, District 2 Hospital, Ho Chi Minh City, Vietnam., Tri Phat N; Department of Pharmaceutical Administratrion, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Truong Van D; Department of Pharmaceutical Administratrion, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Le-Thi TT; Faculty of Pharmacy, Van Lang University, Ho Chi Minh City, Vietnam., Le NDT; Department of Pharmaceutical Administratrion, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Tran-Thi HN; Department of Pharmaceutical Administratrion, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Pham Dinh L; Department of Pharmaceutical Administratrion, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Jazyk:	angličtina
Zdroj:	Health services insights [Health Serv Insights] 2021 Jul 28; Vol. 14, pp. 11786329211036011. Date of Electronic Publication: 2021 Jul 28 (Print Publication: 2021).
DOI:	10.1177/11786329211036011
Abstrakt:	Our objective is to analyze the economic burden of chronic kidney disease (CKD) in Vietnam, particularly in District 2 Hospital at Ho Chi Minh City in 2019. This is a descriptive cross-sectional study. The data source is the medical records of the patients. Encoding the data, analyzing treatment cost, regression modeling, and verification were performed using Stata 15 software. Patients with stage 3 CKD account for the highest proportion of the CKD patient population. CKD comorbidities include hypertension, diabetes, cardiovascular disease, and anemia, which increase the treatment fees of patients. Approximately half of the patients with CKD have diabetes or cardiovascular disease. Treatment costs increase as the condition of the patient worsens (except for stage 1 and 2 CKD). The total expenses of all CKD patients in District 2 Hospital were USD 916 423 988.60. Five main factors that affect the treatment fee of a patient: CKD stage, age, gender, and the presence of diabetes, cardiovascular disease, and anemia. The regression model correctly predicts 96% of cases and can explain 64.15% of the fluctuations in costs. The cost of CKD treatment was higher than Vietnam's per capita GDP in 2019, and the primary factors affecting costs are comorbidities and dialysis. Competing Interests: Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (© The Author(s) 2021.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu